---
title: "CHANG NANCY T — Ownership Dossier"
canonical: https://whiteintel.dev/entity/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21
json: https://whiteintel.dev/api/public/dossier/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21
identifier: sec:0001135041
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# CHANG NANCY T

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001135041`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21  

## Ownership & control

### Holdings / subsidiaries

- **Galera Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **Galera Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **Galera Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **TANOX INC** (director) — https://whiteintel.dev/entity/03b54820-08d5-5d65-9c9d-1374327e264f
- **TANOX INC** (tenpercentowner) — https://whiteintel.dev/entity/03b54820-08d5-5d65-9c9d-1374327e264f
- **Galera Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **Galera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/d29cee4e-6c7d-5845-98d3-81aef0672b42
- **IMMIX BIOPHARMA, INC.** (director) — https://whiteintel.dev/entity/b218e786-d21a-574b-aa93-90bd2fc008c7
- **W&T OFFSHORE INC** (director) — https://whiteintel.dev/entity/1e333e8f-0da4-562c-9c10-689df47122ae
- **MoonLake Immunotherapeutics** (director) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **SCICLONE PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/30631827-162f-5820-b4d4-2e4757cd7f0e
- **SCICLONE PHARMACEUTICALS INC** (directorother) — https://whiteintel.dev/entity/30631827-162f-5820-b4d4-2e4757cd7f0e
- **CHARLES RIVER LABORATORIES INTERNATIONAL, INC.** (director) — https://whiteintel.dev/entity/126aaddd-0bd4-5c92-b5c1-1f6ae4d6c620
- **ASPEN RACING STABLES** (director) — https://whiteintel.dev/entity/3d26c5c9-aac1-5ff6-bc00-3de2556608ea
- **APEX BIOVENTURES ACQUISITION CORP** (director) — https://whiteintel.dev/entity/f61ce300-1f5b-542d-8808-f1757006734d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CHANG NANCY T**. Human view: https://whiteintel.dev/entity/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21 · Structured JSON: https://whiteintel.dev/api/public/dossier/1cc7d3f4-3eff-52d9-b690-2bccc5fa1e21._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._